Individualized management of coagulopathy in patients with end-stage liver disease

HIGHLIGHTS

• who: Tina Tomiu0107 Maheu010diu0107 et al. from the University Hospital Center, , Linz, Austria have published the research: Individualized Management of Coagulopathy in Patients with End-Stage Liver Disease, in the Journal: Diagnostics 2022, 12, 3172. of /2022/
• what: ESDL is accompanied by portal hypertension (PH), the major reason for many complications associated with ESLD.
• future: More clinical research is needed for targeted transfusion protocols and pharmacologic prevention of fibrinolysis to manage complex ESLD patients with liver-associated coagulopathy.

SUMMARY

Of 13 Individualized approaches and a better understanding of coagulopathy . . .

 



If you want to have access to all the content you need to log in!

Thanks :)

Username or E-mail:

If you don't have an account, you can create one here.